HTB homepage • Conference reports • Articles by subject • Subscribe 24 August 2018 Contents Editorial 24 August 2018: vol 19 no 14: AIDS 2018 – next reports… Conference reports 22nd International AIDS Conference (AIDS 2018) – second reports Namibia close to achieving 90-90-90 targets Dolutegravir monotherapy: still no longer recommended in either research or clinical practice Changing comorbidities in HIV positive people older than 60 at London clinic High acceptability of annual digital (finger) exam for early detection of anal cancer in gay men >35 years old High rates of anal HPV infection in gay men using PrEP in IPERGAY: the role of vaccination HCV incidence and reinfection in HIV negative gay men using PrEP in the Netherlands FDA-approved compounds that might selectively reverse HIV latency Lack of impact on viral reservoir with α4β7 monoclonal antibody vedolizumab: macaque results not matched in humans Janssen HIV vaccine: update from APPROACH and largescale efficacy study Viral load testing in Latin America and the Caribbean Access to viral load testing increased from 14% to 61% over two years in Côte d’Ivoire Resolving a diagnosis for people with persistently indeterminate HIV test results 10th International Workshop on HIV Paediatrics – second reports Dolutegravir dispersible tablets for infants and young children: early PK, safety and efficacy Antiretrovirals Top-line phase 3 results released for cabotegravir/rilpivirine long-acting injections Interactions between oral anticoagulants and Genvoya, Stribild and cobicistat: FDA label updates Other news More than ten people a day died from drug-related deaths in England and Wales last year: On the web We learn, we think, we change: Martin Fisher Foundation and Stiggy launch campaign to end stigma PDFs 24 August 2018: vol 19 no 14 HTB homepage • Conference reports • Articles by subject • Subscribe
